Document is current

Any future updates will be listed below

1168 A novel immunostimulatory TLR7/8 agonist is curative as a monotherapy in lewis lung carcinoma and synergizes with anti-PD-1 in B16F10 and MC38 tumor models

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1168

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark